|
|
Webinar | West Pharmaceutical Services, Inc.
|
Explore the challenges related to packaging of cell and gene therapy products and proven solutions to enable speed to market and compatibility, performance of packaging materials.
|
|
|
|
Webinar | Abzena
|
An experienced CDMO can empower developers to implement de-risking strategies that significantly improve both clinical and commercial outcomes for their biologic and bioconjugate programs.
|
|
|
|
Webinar | Catalent
|
Here, we review several challenges in biologics analysis and take a closer look at the advanced tools and methods being utilized to improve biophysical analysis reliability and efficiency.
|
|
|
|
Video | Ajinomoto Bio-Pharma Services
|
Discover how our advanced fill-finish manufacturing capabilities can elevate the success of your project, streamlining processes and enhancing quality at every step.
|
|
|
|
Webinar | Quotient Sciences
|
The following case studies describe specialized formulation technologies that are being used to achieve an optimal target product profile when administering modified-release dosage forms.
|
|
|
|
Webinar | Aton Biotech
|
Delve into the specific challenges encountered in the development of high-concentration formulations and gain an overview of current state-of-the-art solutions for subcutaneous administration.
|
|
|
|
Webinar | Samsung Biologics
|
Where reducing time to market can determine a key factor for a successful business, selecting the right pathway from the start is critical to prevent any future risks. Learn about what to consider.
|
|
|
|
Video | Cambrex
|
Grace Russell, Associate Director of Chemistry, Snapdragon Chemistry, Cambrex shares how finding the right partner who takes the time to ensure processes work together is crucial to your program's success.
|
|
|
|
Webinar | Lonza
|
Consider the following methods for designing and de-risking molecules, streamlining the path to GMP manufacturing and clinical trials, and case studies that provide insight into key activities.
|
|
|
|
Webinar | FUJIFILM Diosynth Biotechnologies
|
Aseptic drug-filling poses significant risks for manufacturers that can increase costs and timelines. Leveraging proven expertise and efficiency can ensure the production of safe, efficacious products.
|
|
|